TY - JOUR A1 - Safarian, Schara A1 - Opel-Reading, Helen K. A1 - Wu, Di A1 - Mehdipour, Ahmad Reza A1 - Hards, Kiel A1 - Harold, Liam K. A1 - Radloff, Melanie A1 - Stewart, Ian A1 - Welsch, Sonja A1 - Hummer, Gerhard A1 - Cook, Gregory M. A1 - Krause, Kurt L. A1 - Michel, Hartmut T1 - The cryo-EM structure of the bd oxidase from M. tuberculosis reveals a unique structural framework and enables rational drug design to combat TB T2 - Nature Communications N2 - New drugs are urgently needed to combat the global TB epidemic. Targeting simultaneously multiple respiratory enzyme complexes of Mycobacterium tuberculosis is regarded as one of the most effective treatment options to shorten drug administration regimes, and reduce the opportunity for the emergence of drug resistance. During infection and proliferation, the cytochrome bd oxidase plays a crucial role for mycobacterial pathophysiology by maintaining aerobic respiration at limited oxygen concentrations. Here, we present the cryo-EM structure of the cytochrome bd oxidase from M. tuberculosis at 2.5 Å. In conjunction with atomistic molecular dynamics (MD) simulation studies we discovered a previously unknown MK-9-binding site, as well as a unique disulfide bond within the Q-loop domain that defines an inactive conformation of the canonical quinol oxidation site in Actinobacteria. Our detailed insights into the long-sought atomic framework of the cytochrome bd oxidase from M. tuberculosis will form the basis for the design of highly specific drugs to act on this enzyme. KW - Bacterial structural biology KW - Bioenergetics KW - Cryoelectron microscopy KW - Structural biology Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63252 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-632525 SN - 2041-1723 N1 - Open Access funding enabled and organized by Projekt DEAL. N1 - This work was supported by the Max Planck Society, the Nobel laureate Fellowship of the Max Planck Society, and the Deutsche Forschungsgemeinschaft (Cluster of Excellence Macromolecular Complexes Frankfurt), Marsden Fund, Anderson Charitable Trusts, Catalyst Fund, and Royal Society of New Zealand. VL - 12 IS - art. 5236 SP - 1 EP - 10 PB - Nature Publishing Group UK CY - [London] ER -